What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Parkinson's disease
The scientist’s investigation covers issues in Parkinson's disease, Disease, Physical therapy, Neurology and Psychiatry.
His Parkinson's disease research entails a greater understanding of Internal medicine.
K. Ray Chaudhuri interconnects Quality of life, Dopaminergic, Observational study and Intensive care medicine in the investigation of issues within Disease.
The Physical therapy study combines topics in areas such as Central nervous system disease, Cross-sectional study, Pramipexole, Retrospective cohort study and Rotigotine.
As a part of the same scientific study, K. Ray Chaudhuri usually deals with the Neurology, concentrating on Severity of illness and frequently concerns with Adverse effect and Prospective cohort study.
His study explores the link between Non motor and topics such as Motor symptoms that cross with problems in Antiparkinson Agents.
His most cited work include:
- Non-motor symptoms of Parkinson's disease: diagnosis and management (1677 citations)
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment (1103 citations)
- The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. (551 citations)
What are the main themes of his work throughout his whole career to date?
Parkinson's disease, Disease, Internal medicine, Physical therapy and Physical medicine and rehabilitation are his primary areas of study.
In his study, which falls under the umbrella issue of Parkinson's disease, Mood is strongly linked to Quality of life.
K. Ray Chaudhuri works mostly in the field of Disease, limiting it down to concerns involving Intensive care medicine and, occasionally, Deep brain stimulation.
He combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine.
His Physical therapy study incorporates themes from Nocturia, Rating scale, Sleep disorder, Randomized controlled trial and Anxiety.
The concepts of his Physical medicine and rehabilitation study are interwoven with issues in Severity of illness and Restless legs syndrome.
He most often published in these fields:
- Parkinson's disease (97.54%)
- Disease (62.95%)
- Internal medicine (27.46%)
What were the highlights of his more recent work (between 2018-2021)?
- Parkinson's disease (97.54%)
- Disease (62.95%)
- Internal medicine (27.46%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Parkinson's disease, Disease, Internal medicine, Dyskinesia and Physical medicine and rehabilitation.
His Parkinson's disease research is mostly focused on the topic Levodopa.
His Disease research includes themes of Psychological intervention and Quality of life.
His research in Internal medicine focuses on subjects like Endocrinology, which are connected to Neuron.
His research in Dyskinesia intersects with topics in Levodopa carbidopa and Neurology.
His studies in Physical medicine and rehabilitation integrate themes in fields like Levodopa-induced dyskinesia, Restless legs syndrome and Rating scale.
Between 2018 and 2021, his most popular works were:
- Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence-based medicine review (208 citations)
- Outcome of Parkinson's Disease Patients Affected by COVID-19. (65 citations)
- Outcome of Parkinson's Disease Patients Affected by COVID-19. (65 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Parkinson's disease
K. Ray Chaudhuri mainly investigates Parkinson's disease, Disease, Internal medicine, Dyskinesia and Levodopa.
His studies deal with areas such as Physical medicine and rehabilitation, Quality of life, Intensive care medicine, Personalized medicine and Pediatrics as well as Parkinson's disease.
He has included themes like Psychological intervention, Quality of life, Retrospective cohort study, Help-seeking and Sexual dysfunction in his Disease study.
His work on Non motor as part of general Internal medicine research is frequently linked to 2019-20 coronavirus outbreak, Pandemic, Outcome and Severe acute respiratory syndrome coronavirus 2, thereby connecting diverse disciplines of science.
His Dyskinesia study which covers Levodopa carbidopa that intersects with Healthcare system, Dose reduction, Retrospective analysis and Concomitant.
Neuropsychology, Number needed to treat and Propensity score matching is closely connected to Cohort in his research, which is encompassed under the umbrella topic of Levodopa.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
